MALARIA LIFE CYCLE WHO qualified; Point of Care useDetects pHRP-II antigen specific to P.f. and LDH antigen specific to P.v.Detects active infection and monitors anti-malaria treatment

Positivia Rapid Test Control kit and WHO

quarlified OnSite Malaria Pf/Pan Ag

Rapid Test also available

Malaria OnSite Diagnostic Solutions

OnSite Pf/Pv Ag Performance

OnSite Pf/Pv Ag Test Features OnSite Pf/Pv Ab Test Features

OnSite Pf/Pv Ag Test Procedure

Detects at least 200 parasites/microliter Highly sensitive and specific No interference by common chemicals and medications

24 month shelf life

OnSite Pf/Pv Ab Test Procedure

OnSite Pf/Pv Ab Performance

Detects IgG, IgM & IgA against P.f. and P.v. MSP antigen Differetiates P.f. from P.v. infection Easy to use Minimal training and no equipment required Uses serum, plasma or whole blood Suitable for blood donor screening

Highly sensitive and specific Clear and easy to interpret test window No interference by common chemicals and medications 18 month shelf life

Malaria threatens approximately half of the world’s population. Globally, 198

million cases of malaria and 584,000 deaths occur annually, with 3.3 billion

people at risk of being infected with malaria.

Malaria is caused by the parasite Plasmodium, which is transmitted to people

through the bites of infected Anopheles mosquitoes. There are four main

human malaria species, P. falciparum (P.f.), P. vivax (P.v.), P. malariae (P.m.) and P. ovale (P.o.). The P. f. and P. v. malaria pose the greatest public health challenge.

OnSite Malaria Rapid Tests enable detection and differentiation of infection with

various plasmodium species in a cost and time effective format.

Distributor information

REGISTEREDFACILITY

CTK-MK-PST-R0110-2016 Rev1.1

OnSite Pf/Pv Ab Performance

Add specimen Add sample diluent Read result Add specimen Add sample diluent Read result

JAN 2016 FEB 2016 MAR 2016 APR 2016 MAY 2016 JUN 2016

JUL 2016 AUG 2016 SEP 2016 OCT 2016 NOV 2016 DEC 2016